High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia

Published:2012-05-16 Issue:134 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Wu David¹,Sherwood Anna²,Fromm Jonathan R.¹,Winter Stuart S.³,Dunsmore Kimberly P.⁴,Loh Mignon L.⁵⁶,Greisman Harvey A.¹,Sabath Daniel E.¹,Wood Brent L.¹,Robins Harlan⁷

Affiliation:

1. Department of Laboratory Medicine, University of Washington, Seattle, WA 98109, USA.

2. Adaptive Biotechnologies, Seattle, WA 98102, USA.

3. Department of Pediatrics Hematology/Oncology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

4. University of Virginia, Charlottesville, VA 22908, USA.

5. Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco, San Francisco, CA 94143, USA.

6. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.

7. Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Abstract

High-throughput sequencing can detect minimal residual disease comparable to multiparametric flow cytometry in T-ALL patients.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference25 articles.

1. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

2. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

3. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

4. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL

5. Minimal Residual Disease in Acute Lymphoblastic Leukemia

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-supervised learning of T cell receptor sequences exposes core properties for T cell membership;Science Advances;2024-04-26

2. Detecting T-cell clonal expansions and quantifying clone survival using deep profiling of immune repertoires;Frontiers in Immunology;2024-04-03

3. Principles of digital sequencing using unique molecular identifiers;Molecular Aspects of Medicine;2024-04

4. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application;Molecular Cancer;2024-02-17

5. Immunosequencing applications in cutaneous T-cell lymphoma;Frontiers in Immunology;2023-12-21